XML 29 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Note 10 - Fair Value Measurement
 3 Months Ended
Jul. 31, 2021
Notes to Financial Statements  
Fair Value Disclosures [Text Block]

Note 10. Fair Value Measurement

 

The following table sets forth by Level within the fair value hierarchy our financial assets and liabilities that were accounted for at fair value on a recurring basis at  July 31, 2021 and May 1, 2021 according to the valuation techniques we used to determine their fair values. There have been no transfers of assets or liabilities among the fair value hierarchies presented.

 

  

Fair Value Measurements

 
  

Level 1

  

Level 2

  

Level 3

  

Total

 

Balance as of July 31, 2021

                

Cash and cash equivalents

 $74,658  $—  $—  $74,658 

Restricted cash

  2,541   —   —   2,541 

Derivatives - asset position

  —   46   —   46 

Derivatives - liability position

  —   (134)  —   (134)
  $77,199  $(88) $—  $77,111 

Balance as of May 1, 2021

                

Cash and cash equivalents

 $77,590  $—  $—  $77,590 

Restricted cash

  2,812   —   —   2,812 

Derivatives - asset position

  —   4   —   4 

Derivatives - liability position

  —   (261)  —   (261)

Acquisition-related contingent consideration

  —   —   (363)  (363)
  $80,402  $(257) $(363) $79,782 

 

A roll forward of the Level 3 contingent liabilities, both short- and long-term, for the three months ended July 31, 2021 is as follows:

 

Acquisition-related contingent consideration as of May 1, 2021

 $363 

Additions

  33 

Settlements

  (400)

Interest

  4 

Acquisition-related contingent consideration as of July 31, 2021

 $— 

 

There have been no changes in the valuation techniques used by us to value our financial instruments since the end of fiscal 2021. For additional information, see our Annual Report on Form 10-K for the fiscal year ended May 1, 2021 for the methods and assumptions used to estimate the fair value of each class of financial instrument.